Vertex (VRTX) director reports stock grant and 796-share deferral
Rhea-AI Filing Summary
Vertex Pharmaceuticals director Diana McKenzie reported routine equity compensation and a deferral election involving company stock. She received a grant of 943 shares of common stock at no cost as a restricted stock unit award that will vest based on the grant terms.
Upon vesting of earlier restricted stock units granted on May 1, 2025, she chose to defer 796 shares of common stock into 796 deferred stock units under Vertex’s deferred compensation plan. This is recorded as a disposition of 796 common shares back to the issuer in exchange for an equal number of deferred stock units.
Each deferred stock unit represents one share of common stock and will be paid in stock upon the earliest of her board service ending, a change of control, or her disability or death. After these transactions, she holds 3,174 shares of common stock directly, 7,787.483 deferred stock units, and 207 common shares held indirectly in a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 796 | $0.00 | -- |
| Grant/Award | Common Stock | 943 | $0.00 | -- |
| Disposition | Common Stock | 796 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.